Glucose Monitoring in Different Metabolism Types
Part of Hormones & metabolism clinical trials.
This study uses a glucose monitoring device (FreeStyle Libre 2) to measure blood sugar patterns in people with different types of diabetes and people with unusual insulin responses. The goal is to understand how blood sugar varies differently depending on the type of metabolism problem someone has.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old
- You fit into one of four specific groups: monogenic diabetes (genetic), type 2 diabetes, high insulin with normal blood sugar, or normal blood sugar with slightly elevated insulin
- You cannot be pregnant
- You cannot have pancreatic autoantibodies (specific immune markers)
- You cannot have severe heart, liver, or kidney disease
- You cannot be currently enrolled in another clinical trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares wearing a continuous glucose monitor (CGM) all the time versus only now and then for people with type 2 diabetes who do not use insulin. It aims to see which way helps manage blood sugar better.
This study checks whether patient-guided lifestyle changes, supported by a continuous glucose monitor (a sensor), can improve blood sugar control in adults with type 2 diabetes. It may help you and your care team see how food, activity, and habits affect your readings.
This study uses a continuous glucose monitor (CGM) and an oral glucose tolerance test (OGTT) to check how well your body controls blood sugar. It is for people who may have early signs of diabetes or are at risk and want to better understand their glucose health.
This trial compares two types of continuous glucose monitors to see which works better for people with type 2 diabetes who use insulin. You will wear a sensor that tracks your blood sugar levels continuously or at set times, and the study will help find the best way to manage your diabetes.
This study tests whether using a continuous glucose monitor (FreeStyle Libre 2) along with smart insulin pens or caps helps people with type 1 diabetes better manage their blood sugar on their own. If you already use this device and take multiple daily insulin injections, you may be eligible.
This study uses a continuous glucose monitor to help people with prediabetes or type 2 diabetes better manage their blood sugar and weight, and will test how well it works in a real-world workplace setting.
Hear when a new Monogenic Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.